Table 1.

Baseline Characteristics and Annual Changes Characteristics of the Study Participants

Variable	Mean(SD), Median (Q1, Q3) Or No. (%)
Baseline
Age, Years	45.0(2.9)
White, n (%)	198 (82.5)
BMI, kg/m²	27.7(4.1)
SBP, mm Hg	122.9(11.5)
Heart rate/minute	64.6(8.8)
Medication for hypertension, n (%)	24 (10.0)
LDL-c, mg/dL	134.5(32.8)
HDL-c, mg/dL	48.5(12.8)
Triglycerides, mg/dL	131.0(94.0,193.0)
Total cholesterol, mg/dL	212.8(37.3)
Medication for lipids, n (%)	27 (11.3)
Glucose, mg/dL	98.0(92.0,105.0)
Insulin, uU/mL	12.8(10.2,17.1)
Medication for diabetes, n (%)	3 (1.3)
Adiponectin, µg/mL	9.8(7.0,13.0)
PAI-1, ng/mL	25.9(15.3,39.2)
CRP, mg/L	1.0(0.5, 2.2)
Fibrinogen, mg/L	290.0(252.0,326.0)
Smoking status Current, n (%) Former, n (%) Never, n (%)	26 (10.8) 45 (18.8) 169 (70.4)
Alcohol consumption ≥2 times/week, n (%)	112 (46.7)
Baseline PWV, cm/s	835.8(744.0, 934.3)
Annual Change
BMI change, kg/m² per Year	0.2(0.4)
SBP change, mm Hg per Year	0.7(2.3)
LDL-c change, mg/dL per Year	−0.4(7.3)
HDL-c change, mg/dL per Year	0.3(2.0)
Triglycerides change, mg/dL per year^*	−0.001(0.1)
Glucose change, mg/dL per year^*	0.02(0.03)
Insulin change, uU/mL per year^*	−0.01(0.3)
CRP change, mg/L per year^*	0.02(0.2)
Relative cfPWV change, % change per year	0.3(5.3)

BMI: body mass index; SBP: systolic blood pressure; LDL-c: low density lipoprotein cholesterol; HDL-c: high density lipoprotein cholesterol; PAI-1: plasminogen activator inhibitor; CRP:C reactive protein; cfPWV: carotid femoral pulse wave velocity.

log transformed